{
  "ticker": "JNJ",
  "target_date": "2025-02-27",
  "actual_date": "2025-02-27",
  "collected_at": "2025-12-08T11:27:29.441612",
  "price": {
    "open": 158.75,
    "high": 160.35,
    "low": 158.18,
    "close": 160.13864135742188,
    "volume": 8364600,
    "change_1d_pct": 0.4,
    "change_7d_pct": 5.64,
    "change_30d_pct": 14.02
  },
  "technicals": {
    "rsi_14": 75.83,
    "sma_20": 152.95,
    "sma_50": 146.02,
    "macd": 4.063,
    "macd_signal": 3.294,
    "macd_histogram": 0.769,
    "bb_upper": 162.63,
    "bb_lower": 143.26,
    "price_vs_sma20_pct": 4.7,
    "price_vs_sma50_pct": 9.67,
    "volume_ratio": 0.95
  },
  "fundamentals": {
    "market_cap": 488870084608,
    "pe_ratio": 19.585909,
    "forward_pe": 19.142452,
    "price_to_book": 6.1586795,
    "price_to_sales": 5.3052135,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.36,
    "pct_from_52w_low": 44.24
  },
  "macro": {
    "spy": {
      "price": 579.97,
      "change_1d_pct": -1.6,
      "change_7d_pct": -4.55
    },
    "vix": {
      "level": 21.13,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 107.24
    },
    "gold": {
      "price": 2883.2
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Building A $1,000,000 Dividend Portfolio: A Strategy For Growth, Income And Risk Management",
      "source": "SeekingAlpha",
      "datetime": 1740679200,
      "summary": "A high net worth dividend portfolio should prioritize capital preservation. Read more about an investment approach that offers diversification and helps generate extra income.",
      "url": "https://finnhub.io/api/news?id=d1598733946b0265a4aa2bc5b8b544b58252b4c9cfb2240b4a67f36ebb3c2056"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It",
      "source": "Yahoo",
      "datetime": 1740664819,
      "summary": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=2fcd2b26e56d7999b546c19d2f923abf09a108ff50753d993eafd0542404825f"
    },
    {
      "headline": "Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds",
      "source": "Yahoo",
      "datetime": 1740663513,
      "summary": "We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other best vaccine stocks to buy now. What Will Trump\u2019s Tariffs Mean for the Pharma Industry? On February ",
      "url": "https://finnhub.io/api/news?id=f4442afa8e5c1c3d266ca28be895de77ea4463f2bf14af9b67124dbf654195b4"
    },
    {
      "headline": "Atai: Following The Path That Spravato Laid And Moving Beyond It",
      "source": "SeekingAlpha",
      "datetime": 1740660314,
      "summary": "Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.",
      "url": "https://finnhub.io/api/news?id=5a8728afcd9574d751d0be982edbad9b1d9817e00d9e76bd1f8d6dee45b7ea03"
    },
    {
      "headline": "Why Novartis Remains A 'Buy' After Beating Expectations Again",
      "source": "SeekingAlpha",
      "datetime": 1740650974,
      "summary": "Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read why I maintain my Buy rating on NVS.",
      "url": "https://finnhub.io/api/news?id=b49f962f627f1665d614d75198e399ec2db6f521a9c90fdc497f9d42746bdc43"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/wk-form4_1740613359.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"
    },
    {
      "form": "8-K",
      "date": "2025-02-26",
      "description": "d863514d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514d8k.htm"
    },
    {
      "form": "8-K",
      "date": "2025-02-20",
      "description": "d866332d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-02-19",
      "description": "xslF345X05/wk-form4_1740005083.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000084/xslF345X05/wk-form4_1740005083.xml"
    },
    {
      "form": "4",
      "date": "2025-02-19",
      "description": "xslF345X05/wk-form4_1740004664.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000082/xslF345X05/wk-form4_1740004664.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}